Connect your AI

Oscar Health OSCR Non-cash inducement payment for convertible note conversion (Note 9)

Non-cash inducement payment for convertible note conversion (Note 9) at other companies

Ionis PharmaceuticalsIONS

$4.09M—

AST SpaceMobileASTS

$88.65M—

Halozyme TherapeuticsHALO

$1.37M—

Bloom EnergyBE

$16.56M—

Ionis PharmaceuticalsIONS

$4.09M—

Bloom EnergyBE

$16.56M—

Other financials

Income statement

Revenue$4.6B+52.6%

Operating income$704.1M+137%

Net income$679.0M+147%

EPS (diluted)$2.07+125%

Balance sheet

Cash & equivalents$4.8B+114%

Total debt$430.9M+43.7%

Total equity$1.7B+24.8%

Total assets$9.3B+59.0%

Cash flow

Operating cash flow$2.6B+198%

CapEx$8.8M-2.6%

Free cash flow$2.6B+200%

Valuation

Market cap$8.56B+4.0%

Enterprise value$4.16B-174%

P/S0.6×-0.2×

Profitability

Operating margin0.1%—

Net margin-0.3%—

FCF margin-8.2%—

Returns & leverage

Return on equity-2.6%—

Debt / equity0.3×0.0×

Current ratio1.1×+0.2×

Where this comes from

Reported directly by Oscar Health in its filing.

Tagged under the XBRL concept oscr:NonCashInducementPaymentForConversionOfConvertibleNotes.

The official record: Oscar Health’s 10-K, filed February 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oscar Health's non-cash inducement payment for convertible note conversion (note 9).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Oscar Health's non-cash inducement payment for convertible note conversion (note 9)?: Oscar Health (OSCR) reported non-cash inducement payment for convertible note conversion (note 9) of $3.33M in Q4 2025.
What does non-cash inducement payment for convertible note conversion (note 9) mean?: This represents the non-cash value of inducements offered to convertible note holders to encourage the early conversion of debt into equity. By converting debt to equity, the company reduces its future interest obligations and strengthens its balance sheet. This is a non-cash accounting entry that reflects the cost of capital structure optimization.